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Tropomyosin – master regulator of actin filament function in the
cytoskeleton
Peter W. Gunning1,*, Edna C. Hardeman1,*,‡, Pekka Lappalainen2,* and Daniel P. Mulvihill3,*
ABSTRACT
Tropomyosin (Tpm) isoforms are the master regulators of the
functions of individual actin filaments in fungi and metazoans. Tpms
are coiled-coil parallel dimers that form a head-to-tail polymer along
the length of actin filaments. Yeast only has two Tpm isoforms,
whereas mammals have over 40. Each cytoskeletal actin filament
contains a homopolymer of Tpm homodimers, resulting in a filament
of uniform Tpm composition along its length. Evidence for this ‘master
regulator’ role is based on four core sets of observation. First, spatially
and functionally distinct actin filaments contain different Tpm
isoforms, and recent data suggest that members of the formin
family of actin filament nucleators can specify which Tpm isoform is
added to the growing actin filament. Second, Tpms regulate whole-
organism physiology in terms of morphogenesis, cell proliferation,
vesicle trafficking, biomechanics, glucosemetabolism and organ size
in an isoform-specific manner. Third, Tpms achieve these functional
outputs by regulating the interaction of actin filaments with myosin
motors and actin-binding proteins in an isoform-specific manner.
Last, the assembly of complex structures, such as stress fibers and
podosomes involves the collaboration of multiple types of actin
filament specified by their Tpm composition. This allows the cell to
specify actin filament function in time and space by simply specifying
their Tpm isoform composition.
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Introduction
Tropomyosin (Tpm) is best known for its role in the regulation of
contraction of skeletal muscle and the heart. The contraction of these
striated muscles involves the synchronized movement of myosin
heads that are engaged with actin filaments to produce a net
translocation of the myosin thick filament with respect to the actin
thin filament (Geeves, 2012; Lehrer and Geeves, 2014). The actin
thin filament is composed of three core elements: a double-stranded
polymer of actin, two continuous polymers of Tpm running along
each side of the actin and the troponin complex, a heteromeric
protein complex consisting of troponin T (TnT), troponin I (TnI)
and troponin C (TnC), which is located on each Tpm dimer
(Lehman and Craig, 2008). In response to a pulse of Ca2+ the
troponin complex moves the position of the Tpm polymer to
facilitate the coordinated engagement of the heads of the myosins in
the thick filament with actins in the thin filament.
The discovery of Tpm in mammalian non-muscle cells in the mid-
1970s by Elias Lazarides, naturally, led to the expectation that Tpm
has a similar function in these cells compared with its role in skeletal
muscle cells (Lazarides, 1975). Immunofluorescence experiments led
Lazarides to propose the existence of two populations of actin
polymers in non-muscle cells, those that containedTpmand those that
did not (Lazarides, 1976). In hindsight, it is difficult to understand
how the discussion of the potential significance of Tpm as a core
component of the actin filament in the non-muscle cytoskeleton
slowly disappeared from the literature. There are several simple
explanations that are likely to account for this. First, Tpms are difficult
to work with in protein chemistry experiments because, in solution,
they are largely unstructured and have a tendency to oligomerize and/
or aggregate. Furthermore, Tpm dimers bind F-actin only with very
low affinity (Kd∼10−3 M) (Wegner, 1979) and their efficient
incorporation into an actin filament requires the formation of a
head-to-tail Tpm polymer, consisting of homopolymers of Tpm
dimers that run along the actin filament (Tobacman, 2008). Finally,
Tpms only interact with actin through ionic interactions and, in
essence, ‘float’ above the surface of the actin polymer, making them
unlike most other actin-binding proteins (von der Ecken et al., 2015).
The significance of Tpm has been brought into focus by a recent
analysis, which showed that evolution has selected for increasing
diversity of actin filament composition and that, in the case of fungi
and metazoans, Tpms have provided this diversity (Gunning et al.,
2015). This Commentary examines the functional consequences of
using Tpms to diversify the actin filament composition in the
cytoskeleton of fungi and metazoans, and will make the case that
Tpms are the master regulators of cytoskeletal actin filament function
in these organisms. We focus on four main issues: (i) the mechanism
of assembly of actin filaments that contain homopolymers of specific
Tpm isoforms, (ii) the physiological function of specific populations
of actin filaments that contain different Tpms, (iii) the mechanism by
which different Tpms direct different functional outcomes and (iv)
how different Tpm-containing filaments contribute to the assembly of
large-scale actin-based structures. Where mammalian Tpms are
specified in the text, we will use the new nomenclature (see Geeves
et al., 2015; supplementary Table 1).
Assembly of specific Tpms into actin filaments
Most fungi and metazoan cells have the capacity to express multiple
isoforms of Tpm, resulting from either different gene products
or different post-translational modifications. The biophysical
properties of each Tpm filament and the specific way in which they
interactwith actin can differ significantly. This cooperative interaction
with the actin polymer is crucial for Tpm function because it regulates
interactions with other actin-binding proteins (e.g. myosins and
cofilin) (Bryce et al., 2003), aswell as the biophysical and/or dynamic
properties of the actin filament. Different Tpms are, therefore, able to
impart distinct physical properties to different actin filaments and,
thereby, dictate their function.Asmanycell types can expressmultiple
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Tpm isoforms, it is crucial for the viability, function and mobility of a
cell to recruit the appropriate Tpm to an actin polymer at the correct
place and time (Bach et al., 2009). Indeed, we know that different
Tpms are sorted to different actin filament populations in many
systems and cell types, but how this is brought about is not yet fully
understood (Vindin and Gunning, 2013).
The weak binding of Tpm dimers to actin can only result in a
continuous polymer of Tpm along an actin filament through head-to-
tail contacts between individual Tpm dimers (Tobacman, 2008). The
Hitchcock-DeGregori group has long supported a model whereby
the actin–Tpm interaction is promoted by discrete actin-binding
domains that are present in the Tpmmolecule (Singh and Hitchcock-
DeGregori, 2006), thus restraining the structural conformation of the
actin–Tpm complex. In contrast, others support models where the
complementary shape and charges at the interface between the
coiled-coiled-coil (polymers of the coiled-coil dimer have an
intrinsic coiled shape) Tpm polymer and actin filament result in
the Tpm dimer associating with actin with sub-micromolar affinity,
yet still allowing movement across its surface to regulate interactions
with other actin-binding proteins (Holmes and Lehman, 2008).
However, the precise nature of the actin–Tpm interaction is likely to
remain the subject of controversy for some time to come.
The situation is complicated further by the fact that the relatively
abundant Tpm isoforms that are expressed in a cell can each have
different affinities for actin. Affinity for actin is, therefore, probably
not the only factor that determines the association of a specific Tpm
with actin because it would be very unlikely that weak binding and/
or non-abundant Tpms are found to interact with actin in vivo. The
situation is clearly illustrated in metazoan cells that can express
more than eight different Tpm isoforms, many with comparable
high affinities for actin (Schevzov et al., 2011). Therefore, the cell is
faced with a problem because the highly abundant isoforms with
high affinities would bind to all of the actin polymers in an
unregulated manner (thus precluding models in which actin-binding
sites on the Tpm molecule initiate the actin–Tpm association in a
cell that expresses multiple Tpms) and because Tpm levels are
limiting compared with those of actin polymers – as shown for yeast
and a number of mammalian cell types (McMichael and Lee, 2008;
Marguerat et al., 2012; Schevzov et al., 2008; Kee et al., 2015).
A mechanism must, therefore, exist to ensure that highly specific
actin–Tpm polymers can be formed in a manner that can be flexibly
regulated within time and space. Such a mechanism, of ensuring that
the correct Tpm is recruited to the correct actin filament, is likely to
vary between cell types, depending on the dynamics of the actin
cytoskeleton and the needs of the cell. For example, within a
sarcomere, the actin polymer is stable and does not continually grow
and shrink as is the case in a growing cell. Lehman and Holmes have
proposed a so-called ‘Gestalt model’ (Holmes and Lehman, 2008),
where the most highly abundant and stable Tpm dimer within the
muscle cell (usually an αβ heterodimer) associates randomly along
the actin filament and grows into Tpm polymers from these seed
points. Although this implies a certain spatial synchronicity along an
actin–Tpm polymer, this model allows the cell to exchange the Tpm
on the stable actin polymers throughout its life. However, this model
does not take into account the dynamic situation within growing or
migrating cells, where individual actin polymers undergo regular
cycles of growth and shrinkage. It is clear that, in these cells, a
mechanism must exist to regulate which Tpm binds to the growing
actin polymer in order to define Tpm specificity, thereby modulating
the functional properties of the actin filament.
A number of models can explain the mechanism for defining
Tpm specificity. Although isoform-specific transport to different
intracellular locations is one possibility, studies in which
cytoskeletal drugs were used have comprehensively ruled this out
(Schevzov et al., 1997). It was found that isoform sorting depended
on the maintenance of polymeric structures, and that destruction of
these structures in response to actin-polymerization- and
microtubule-inhibiting drugs dispersed sorted Tpm isoforms
throughout the cell (Gunning et al., 1998). Instead, the spatial
specificity of Tpms appears to be controlled through localized
filament assembly (Schevzov et al., 1997). Similarly, a more recent
study ruled out a Tpm transport mechanism that depends upon
‘sorting signals’ and demonstrated that sorting only functions in the
context of actin–Tpm polymer formation, consistent with the notion
that a Tpm isoform is being held in place through assembly into
isoform-specific polymeric structures (Martin et al., 2010).
There has been growing evidence that actin organizes into
polymers of different conformation (Egelman and Orlova, 1995),
not only owing to differences in the actin isoforms and the discrete
nucleotide-binding states but also through different co-factor
interactions (e.g. Galkin et al., 2010). Subtle differences in the
shape of an actin polymer can affect the affinity of different actin-
binding proteins including, probably, specific Tpm isoforms to
ensure the same Tpm isoform associates along the length of a given
actin filament. By contrast, the interaction between actin and a
specific Tpm is necessary to perpetuate specific structural constraints
along the entire length of the actin–Tpm polymer. However this does
not address the question of what molecule or event initiates the
interaction between a specific Tpm and actin and, thus, determines
the functional properties of the actin–Tpm polymer. One class of
candidate molecules are actin nucleators (e.g. the Arp2/3 complex,
formins or spire proteins), which not only have a preference for
specific types of actin (e.g. profilin-bound actin isoforms), but also
can define the organization of actin filaments (e.g. branched network
or straight filaments). In addition, they also affect the structure of
individual actin filaments (Bugyi et al., 2006) and control which
stabilizing actin-binding proteins interact with the actin filament (e.g.
fimbrin) orwith Tpm (Tang andOstap, 2001; Skau andKovar, 2010).
Together, these ideas led to the development of a model, in which
formins orchestrate the Tpm composition of the actin polymer at the
time of nucleation (Fig. 1) (Johnson et al., 2014). This model fits
well with previous findings (Martin et al., 2010) because it explains
how Tpm sorting can occur in the context of actin–Tpm co-
polymerization on a growing actin filament. Furthermore, there has
been direct in vivo evidence from the fission yeast model system
(Johnson et al., 2014). This yeast contains a single Tpm (Cdc8),
which exists in either an N-terminally acetylated (80% of total Tpm)
or non-acetylated state (Johnson et al., 2014), with the acetylated
Tpm associating with actin filaments that are incorporated into the
cytokinetic actomyosin ring during mitosis and the unacetylated
form associating with more-dynamic actin filaments during
interphase (Skoumpla et al., 2007; Coulton et al., 2010). Indeed,
forcing the mitotic and interphase formins to switch location, led to
a corresponding switch in the acetylated state of Tpms within each
actin–Tpm polymer, which – in turn – was shown to redirect the
location of the myosin motors in the cell (Johnson et al., 2014). This
aligns well with the observation that the formin Dia2 may be
responsible for recruiting Tpm4.2 in an isoform-specific manner to
actin filament arcs in U2OS cells, which, in turn, appears to recruit
MyoIIA to these filaments (Tojkander et al., 2011). Thus, formins
have been shown to play a key role in determining the Tpm
composition and physical properties of an actin polymer.
How the formin defines the Tpm isoform composition of the actin
filament is still unresolved (Fig. 1). However, the difference in the
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N-terminal acetylation state observed in the study by Johnson et al.,
2014 suggests that the N-terminus of the Tpm is key – consistent with
the fact that formins are located at the barbed end of actin filaments
where they can associate with the N-termini of the Tpm dimer
incorporated into the growing actin polymer (Galkin et al., 2011).
Consistent with this, many Tpm isoforms that have a sub-micromolar
affinity for actin in their non-acetylated state, e.g. the non-muscle
tropomyosins Tpm4.2 and Tpm3.1 (also known as Tm4 and
Tpm5NM1, respectively) are acetylated at their N-termini in vivo,
supporting the idea that acetylation alsomodulates theTpmN-terminus
to promote interactions with a specific actin-binding protein (e.g.
formin), or modulates actin-binding in the case of some Tpms, such as
budding yeast Tpm1 and Tpm2 or the skeletal muscle Tpms. Such
direct interaction between a formin molecule and Tpm is consistent
with the variability in the N-termini of most Tpms, which differ
significantly with even subtle differences in fission yeast. Furthermore,
Tpm itself can regulate the interactionbetween formins and thegrowing
(i.e. barbed) end of actin (Ujfalusi et al., 2012; Wawro et al., 2007).
As well as interacting with the barbed end of actin, formins
can also associate with the lateral surfaces of the actin filament
(Bugyi et al., 2006; Martin and Chang, 2006). Therefore, as well
as interacting directly with a preferred Tpm, the formin can
directly modify the pitch of the actin filament, which could in turn
modulate its affinity for specific Tpms (Bugyi et al., 2006; Papp
et al., 2006).
Although different mechanisms probably exist to define the Tpm
specificity on actin polymers, they all have important implications
when it comes to maintaining the N-termini of endogenous Tpm
proteins during in vivo and in vitro studies. For example, placement
of a protein tag might disrupt the normal localization and
cooperative properties of a Tpm filament with regard to its
interactions with other actin-binding proteins such as myosins.
Thus, unlike the majority of proteins, fusing tags to any position of
the Tpm protein will impact on the regulation and/or function of the
protein, and this consequence should be carefully considered when
designing experiments that involve Tpms.
Taken together, is it clear that the Tpm composition of the actin
polymer has a substantial impact upon the physical and functional
properties of the actin filament. It is, therefore, crucial that the























Fig. 1. Models for the formin-directed assembly of actin filaments containing specific Tpm isoforms. (A) In the simplest model that describes the isoform-
specific recruitment of Tpms, different actin isoforms (depicted in white and cream) assemble into polymers with different structural conformations. Each then
associates with a specific Tpm isoform (depicted in green and yellow). As there is a small number of actin isoforms within a cell (up to three different isoforms
depending on the cell type) relative to the Tpms, this mechanism does not explain how all Tpms within one cell are recruited to specific actin structures. (B) In a
simple mechanism that has been described previously (Johnson et al., 2014), a formin nucleates the growing actin polymer and then determines the Tpm
composition of the actin polymer. The precise temporal order of how the formins, actin and Tpm come together is unclear. We outline three possibilities (i,ii, iii) on
how this might happen. (i) Once the formin (red split ring) has initiated the nucleation of an actin polymer of sufficient length, the Tpm isoform (green filament) is
recruited through its specific N-terminus to the formin and then integrated onto the formin-actin-polymer structure. (ii) Actin and the specific N-terminus of a Tpm
polymer associate directly and simultaneously with a formin. Newactin and Tpm subunits are then added in order to polymerize the actin-Tpm cable. (iii) A specific
Tpm isoform interacts directly with a specific formin before actin nucleation starts. Each possibility provides a simple mechanism to explain the assembly of
specific formin-Tpm-actin-polymer structures, i.e. one type of formin (red) promotes assembly of actin filaments decorated with one Tpm isoform (green).
(C) Another type of formin (blue) generates actin polymers stabilized by another Tpm isoform (orange) using the processes described in (B, i-iii). By considering
every combination of different actin and formin isoforms within one cell type, the abovemechanisms provide sufficient opportunity to recruit different Tpm isoforms
to specific actin polymers in order to fine-tune their distinct physical properties, dynamics and functions.
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at the right place and at the right time. The role formins and other
actin-binding proteins have in this is currently the subject of
extensive investigations.
Physiological functions of actin filaments that contain
different Tpms
The first evidence that Tpms are involved in a range of
physiological processes came from elimination of the Tpm1 gene
in budding yeast, which led to defects in cell size and growth,
mating and vesicle transport (Liu and Bretscher, 1989, 1992).
Since then, a substantial body of evidence points to a variety of
specific physiological functions that are regulated by Tpms in an
isoform-specific manner and in a variety of organisms at the level
of the organism (summarized for the main mammalian Tpm
isoforms in Table 1). This supports the notion that the presence of
different Tpms defines the functional capability of specific actin
filament populations in a variety of cellular and physiological
processes, as discussed below.
Embryogenesis
All four mammalian Tpm genes (Tpm1, Tpm2 Tpm3, Tpm4) are
expressed in mouse embryonic stem cells (Muthuchamy et al.,
1993; Hook et al., 2004). Despite this, it has so far been impossible
to delete both copies of the Tpm3 gene (Hook et al., 2004) because
all Tpm3-knockout mice embryos died prior to implantation in the
uterus. Furthermore, 50% of mice that lack just two isoforms of the
Tpm3 gene failed to survive embryogenesis and it was impossible to
generate embryonic stem cells that lack these isoforms in cell culture
(Hook et al., 2011). Thus, none of the other three active Tpm genes
can compensate for Tpm3, indicating a gene-specific function.
Tpm3.1 has been shown to regulate organ size and cell proliferation
in mice (Schevzov et al., 2015), and another recent study has
Table 1. Summary of the main mammalian Tpm isoforms and their functions
Tpm Isoform Function References
Tpm1.6 Rescues transformed cells Gimona et al., 1996
Stabilizes stress fibers Tojkander et al., 2011, 2012
Inhibits Myo1b and 1c binding Tang and Ostap, 2001; Kee et al., 2015
Tpm1.7 Forms filipodia with cofilin Creed et al., 2011
Inhibits neuronal morphogenesis Schevzov et al., 2005
Preferentially binds fascin Creed et al., 2011
Tpm1.8, Tpm 1.9 Regulates CFTR in the membrane Dalby-Payne et al., 2003
Regulates mammary gland differentiation Zucchi et al., 2001
Localizes to epithelial cell-cell junctions and cell periphery Temm-Grove et al., 1998; Schevzov
et al., 2011
Tpm1.10, Tpm 1.11, Tpm
1.12
1.10, 1.11, 10.12 Promote MAP2C expression Curthoys et al., 2014
1.10 Inhibits neurite arborization and growth cone size Curthoys et al., 2014
1.11 Promotes neurite length Curthoys et al., 2014
1.12 Promotes neurite formation, arborization, growth cone size and filopodia
along the neurite
Curthoys et al., 2014
1.12 Does not impact Arp2/3-mediated actin assembly Kis-Bicskei et al., 2013
1.12 Promotes binding of cofilin Bryce et al., 2003
Tpm2.1 Reduction associated with transformation Stehn et al., 2006
Regulates anoikis Raval et al., 2003
Associated with establishing focal adhesions Tojkander et al., 2011, 2012
Restores stress fibers in transformed cells Prasad et al., 1993
Tpm3.1 Expressed in tumor cells Stehn et al., 2006, 2013
Regulates glucose uptake Lim et al., 2015; Kee et al., 2015
Regulates insulin-stimulated GLUT4 transport to plasma membrane Kee et al., 2015
Required for ERK-mediated proliferation Schevzov et al., 2015
Regulates cell motility and migration Bach et al., 2009; Lees et al., 2013
Preferentially recruits MyoIIA Bryce et al., 2003
Strongly inhibits cofilin severing Bryce et al., 2003
Inhibits Arp2/3-mediated actin assembly Kis-Bicskei et al., 2013
Maintains T-tubule structure Vlahovich et al., 2009
Regulates excitation-contraction coupling Vlahovich et al., 2009
Regulates contractility and integrity of the epithelial zonula adherens Caldwell et al., 2014
Promotes neurite branching Schevzov et al., 2005
Tpm3.2 Associated with Golgi-derived vesicles Percival et al., 2004
Regulates contractility and integrity of the epithelial zonula adherens Caldwell et al., 2014
Tpm4.2 Expressed in tumor cells Stehn et al., 2013
Transiently recruits Myosin II motors Tojkander et al., 2011, 2012
Localizes to specialized membranes Kee et al., 2009b
Promotes MAP2C expression Curthoys et al., 2014
Promotes neurite formation, arborisation, growth cone size and filopodia along
the neurite
Curthoys et al., 2014
Localizes to terminal sarcoplasmic reticulum Vlahovich et al., 2009
Associated with myofiber formation, growth and repair/regeneration Vlahovich et al., 2008
Over 40 potential Tpm isoforms have been described in mammalian cells. Among these are isoforms that are considered to be the main mammalian Tpms
(Schevzov et al., 2011). These Tpms are listed with current key information; however, theremay be other Tpm isoforms that have important roles in cells. This brief
overview is only intended to serve as a ‘primer’ for those readers new to the field, and the list of functions is not exhaustive.
4













reported that a Drosophila Tpm also promotes cell proliferation
(Goins and Mullins, 2015).
Morphogenesis
The role of different Tpm isoforms in morphogenesis has been
studied most extensively in neurons and has revealed a wide array of
morphological roles for Tpm3.1. This isoform promotes increased
axon length, growth cone size and dendritic branching, whereas
expression of the non-neuronal Tpm1.7 (also known as Tm3)
in neurons attenuates neurogenesis (Schevzov et al., 2005).
By contrast, knockout of Tpm3.1 and Tpm3.2 (also known as
Tm5NM2) resulted in a decrease in the size of growth cones with an
increased rate of lamellipodia protrusions (Fath et al., 2010). Loss-of-
function mutations in the Tm2 (also known as TmII) gene in
Drosophila leads to cell autonomous expansion of neuronal dendritic
fields (Li and Gao, 2003). Elevated expression of a range of Tpm
isoforms in B35 neuroblastoma cells results in a plethora of
phenotypes in differentiated cells, which is consistent with an
isoform-specific impact on morphogenesis (Curthoys et al., 2014).
Tpm1.7 promotes the formation of filopodia in B35 cells (Creed et al.,
2011), which is dependent on the availability of active cofilin. In
epithelial cells, Tpm3.1 is necessary for the stability of cell–cell
junctions, and its deletion in mice greatly reduces the levels of
junctional E-cadherin in the kidney (Caldwell et al., 2014). In addition
to neurons, Tpm1.9 (also known as Tm5b) was shown to be essential
for morphogenesis in a cell model of mammary gland differentiation
(Zucchi et al., 2001), and Tpm1.1 (also known as alpha-Tm) is
essential for development of the heart (Rethinasamy et al., 1998)
Cell trafficking and cytokinesis
Injection of Tpm1.7 protein into normal rat kidney (NRK) cells led
to accumulation of organelles in the perinuclear space, whereas
injection of Tpm3.1 had no impact (Pelham et al., 1996). This
suggests that specific Tpm isoforms impact on organelle
trafficking, which might reflect their differential effect on
myosin motors. For instance, Ostap and co-workers have shown
that Myo1b, which is involved in organelle transport, does not
recognize actin filaments that contain either Tpm1.6 (also known
as Tm2) or Tpm3.1 (Tang and Ostap, 2001; Kee et al., 2015;
McIntosh et al., 2015). In addition, Tpm1.8 (also known as Tm5a)
and Tpm1.9 regulates the recycling of the cystic fibrosis
transmembrane receptor (CFTR) (Dalby-Payne et al., 2003).
Tpm1.8 and Tpm1.9 are enriched at apical sites, which are also
enriched for CFTR, and depletion of Tpm1.8 and Tpm1.9 leads to
elevated levels of CFTR in the apical membrane. This is consistent
with a role for Tpm1.8 and Tpm1.9 in recycling of CFTR from the
plasma membrane. Tpms are also involved in cytokinesis, and a
fission yeast Tpm has been shown to be essential for cytokinesis
(Balasubramanian et al., 1992). Expression of a mammalian
hybrid Tpm results in defects in cytokinesis in Chinese hamster
ovary (CHO) cells (Warren et al., 1995). Moreover, the balance
between the protein levels of Tpm2.1 (also known as Tm1) and
cofilin is important in ensuring efficient cytokinesis in mammalian
cells (Thoms et al., 2008).
Skeletal muscle
Deletion of Tpm3.1 and Tpm3.2 in mice impacts on the
morphological and functional features of skeletal muscle. Loss of
Tpm3.1 fromT-tubules results in increased T-tubule dysmorphology
(Vlahovich et al., 2009). In addition, altered excitation-contraction-
coupling has been observed which is consistent with an altered
uptake of Ca2+ through the triad, possibly because of changes in
T-tubule function (Vlahovich et al., 2009). In addition, expression of
the cytoskeletal Tpm1.7, but not of Tpm3.1, in skeletal muscle
results in muscular dystrophy (Kee et al., 2009a). This specificity in
the effect of cytoskeletal Tpm isoforms mirrors the studies fromD. F.
Wieczorek’s laboratory that demonstrated that isoform switching of
striated muscle Tpm isoforms in the heart impacts on cardiac
function (Jagatheesan et al., 2010a,b).
Metabolism
The actin cytoskeleton has been implicated in glucose transport for
some time (Klip et al., 2014), and two recent studies have
demonstrated that Tpm3.1-containing actin filaments regulate
glucose uptake in mice in an isoform-specific manner (Lim et al.,
2015; Kee et al., 2015). Here, insulin stimulation of Akt was shown
to result in phosphorylation of Tmod3, which caps Tpm3.1-
containing actin filaments that are involved in actin reorganization at
the cell periphery and increased incorporation of GLUT4 into the
plasma membrane (Lim et al., 2015). The other study showed that
elevated levels of Tpm3.1 in transgenic mice result in increased
glucose uptake, whereas the corresponding knockout mouse shows
reduced glucose uptake following a high-fat diet (Kee et al., 2015).
The authors provided evidence for the existence of at least two
populations of actin filaments that are required for insertion of
GLUT4 into the plasma membrane, onewhich contains Tpm3.1 and
engages MyoIIA, and a second which lacks Tpm and interacts with
Myo1c (Kee et al., 2015).
Cancer
It has been known for several decades that Tpms are sensitive
markers of the transformed state of a cell (Hendricks andWeintraub,
1981, 1984; Lin and Leavitt, 1988; Novy et al., 1993). The original
observation was that the level of a subset of Tpms is reduced during
transformation and correlates with a loss of actin stress fiber bundles
(Leonardi et al., 1982; Matsumura et al., 1983; Urbanciková et al.,
1984). Subsequent studies have shown that there is a close
correlation between the loss of Tpm2.1 from cells and their
transformation, and that restoring the levels of Tpm2.1 or Tpm1.6
reverses specific features of transformation (Boyd et al., 1995;
Gimona et al., 1996; Bharadwaj et al., 2005). However, the loss of
these Tpms is not an absolute predictor of transformation. By
contrast, all tumour cells retain Tpm3.1 (Stehn et al., 2006). A role
for Tpm3.1 in transformation and, in particular, in cell motility had
been first described about a decade earlier (Miyado et al., 1996,
1997). More recent work has confirmed that Tpm3.1 is required for
the survival of neuroblastoma in colony-forming assays and
regulates cell proliferation through the MAPK pathway (Stehn
et al., 2013; Schevzov et al., 2015).
Cell biomechanics
The actin cytoskeleton has been implicated in the regulation of the
biomechanical properties of cells (Wakatsuki et al., 2001). The
mechanical interaction of myosin II motors with actin filaments
has been shown to play a major role in determining the stiffness
of the cell cortex (Alenghat and Ingber, 2002). Not surprisingly,
Tpm isoforms have been found to regulate cell stiffness in a
neuroblastoma cell model (Jalilian et al., 2015). The cancer-
associated Tpm3.1 has the greatest ability to increase cell stiffness
in this model and its effect depends on myosin II. The ability of
Tpms to regulate cell stiffness is isoform dependent and is
independent of their level of expression or their effect on actin
bundles, suggesting that it reflects an impact on actin organization
at a more subtle level (Jalilian et al., 2015). This could be reflected
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in differences in the ability of Tpms to influence filament stiffness
(Kojima et al., 1994) or flexibility in the presence of cofilin
(McCullough et al., 2008).
On the basis of the above studies, it is to be expected that genetic
manipulation of Tpms will reveal specific roles for the different
Tpm isoforms in many, if not most, physiological processes owing
to their ability to uniquely define the functional characteristics of
the actin filaments that are engaged in specific processes. It is
surprising, however, that no mutations in human cytoskeletal Tpms
have been associated with disease, whereas many mutations in
muscle Tpms are associated with muscle conditions (Marttila et al.,
2014). The development of drugs that target specific Tpm isoforms
might open the door to a range of therapeutic opportunities, such as
the treatment of cancer (Stehn et al., 2013). The development of
drugs that specifically target a subpopulation of actin polymers will
also help the identification of the specific Tpm isoforms that
underlie particular physiological functions.
Mechanism of function of different Tpm isoforms
As discussed above, different Tpm isoforms have the ability to
specify the function of actin filaments by regulating their
interactions with myosin motor and actin-binding proteins. The
most extensive data concern the interaction with myosins. The initial
indication that Tpms can regulate myosin motor activity came from
studies investigating the effect of two different Tpms on a myosin II
motor in vitro (Fanning et al., 1994), and showed that myosin II
activity depends on the type of Tpm present. Subsequent work
demonstrated that Tpm1.6 was able to account for the intracellular
location of Myo1b by excluding its interaction with actin filaments
that contain Tpm1.6 (Tm2) (Tang and Ostap, 2001). The ability of
Tpms to also prevent Myo1c from interacting with actin filaments
has been observed both in other cells and in in vitro systems (Kee
et al., 2015; McIntosh et al., 2015).
Furthermore, elevated expression of Tpm3.1 (Tm5NM1), but not
of Tpm1.12 (TmBr3), resulted in the recruitment of myosin II
isoforms to different actin filament populations (Fig. 2) (Bryce et al.,
2003). Here, MyoIIA was recruited to actin cables that span the
cytoplasm of B35 neuroblastoma cells, whereas MyoIIB was
enriched at the cell periphery and found associated with membrane
arcs. Several groups have shown that in yeast, the type of Tpm that is
associated with actin filaments determines the recruitment of
different motors to these filaments (Stark et al., 2010; Clayton et al.,
2010; Coulton et al., 2010). A more recent study extended this
notion and showed that Tpm enables a class-V myosin motor to
move along an actin filament (Hodges et al., 2012).
The function of cofilin at actin filaments is also regulated by
Tpms in an isoform-specific manner (Kuhn and Bamburg, 2008). In
fact, initially, Tpm had been identified as a competitor of cofilin
because it prevents cofilin-mediated severing of actin filaments
(Bernstein and Bamburg, 1982). Subsequent genetic studies
confirmed this competitive relationship between Tpm and cofilin
in C. elegans (Ono and Ono, 2002) and yeast (Nakano and
Mabuchi, 2006). However, the effect of Tpm on cofilin appears to
be isoform-specific because, in contrast to Tpm3.1 that antagonizes
cofilin activity in B35 cells, two other Tpms were shown to
collaborate with cofilin in the same cells (Bryce et al., 2003; Creed
et al., 2011) (Fig. 2). This has led to the suggestion that, depending
on the particular isoforms, Tpms and cofilins either compete with
each other or act in a cooperative manner (Kuhn and Bamburg,
2008). Similarly, the ability of gelsolin to sever actin filaments is
regulated by the type of Tpm that is associated with the target
filament. For instance, some Tpms can partially protect actin
filaments from severing, whereas other Tpms do not provide such
protection (Ishikawa et al., 1989a,b), and this extends to their ability
to bring together actin filaments that have been severed by gelsolin






















Fig. 2. Tpm isoforms regulate the
interactions of actin filaments with actin-
binding proteins. Tpm 3.1, Tpm 1.12 and
Tpm1.7 have different impacts on the
association of myosin II, ADF/cofilin and
fascin with actin filaments (Bryce et al., 2003;
Creed et al., 2011).
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Tpms are able to confer quite different functional properties onto
actin filaments.
The actin-bundling protein fascin is also differentially affected by
different Tpm isoforms. Elevated expression of Tpm1.7 promotes
the formation of filopodia in B35 cells that is paralleled by elevated
levels of fascin (Creed et al., 2011) (Fig. 2). This suggests that fascin
becomes more stable if it is more efficiently incorporated into actin
filament structures (i.e. less likely to be degraded if it is associated
with actin) and correlates with the finding that fascin preferentially
associates with Tpm1.7, compared with the closely related isoform
Tpm1.6 (Creed et al., 2011). Thus, a change in the number of actin
filaments that contain a specific Tpmmight lead to an increase in the
levels of actin-binding proteins that bind to filaments with this
particular Tpm, because this association might reduce their turnover
kinetics.
Tpm itself can also regulate actin polymerization through two
main means. First, Tpm mechanically stabilizes actin filaments,
thereby promoting the formation of longer actin filaments by
reducing the probability of severing during elongation (Hitchcock-
DeGregori et al., 1988). Second, Tpm decreases the rate by which
actin is removed from the pointed end of the actin filament, i.e. the
end from which actin depolymerization usually occurs (Broschat
et al., 1989). In addition, Tpm collaborates with tropomodulins in an
isoform-specific manner to further stabilize the pointed end of the
filament. Tropomodulins bind to the pointed end of an actin
filament, and to both actin and the associated Tpm (Fowler, 1990;
Vera et al., 2000; Rao et al., 2014). The observed differences in the
binding affinities of different Tpm isoforms to tropomodulins
contribute to the fine-tuning of the stability of the pointed end of an
actin filament (Fischer and Fowler, 2003).
Finally, Tpm supply is limiting for the determination of steady-
state actin polymer levels in the cell. Elevated expression of Tpm3.1
in mouse brain results in increased levels of actin polymer in the
growth cones of primary neurons (Schevzov et al., 2008). Similarly,
elevated levels of Tpm3.1 and Tpm1.7 result in increased actin
polymerization in mouse fat pads, whereas knockout of Tpm3.1
results in a corresponding decrease in actin polymerization within
fat pads (Kee et al., 2015). Therefore, the level of expression of a
specific Tpm isoform is expected to determine the number of actin
polymers in a tissue that contain this isoform. In line with this,
Tpm4.2 has been shown to be a limiting factor for actin polymers
that are associated with podosomes (McMichael and Lee, 2008).
Thus, Tpms provide actin filaments with very different
capabilities in terms of the way in which individual filaments are
crosslinked, are susceptible to severing and engage with different
myosin motors. This allows a cell to pick and choose different
filament capabilities when establishing cytoskeletal structures.
Role of Tpm-containing filaments in cytoskeletal structures
The functional diversity of cellular actin filament populations is well
exemplified by the roles of Tpms in stress fiber assembly. Stress
fibers are the main contractile actomyosin bundle in many non-
muscle cell-types, where they have an important role in adhesion,
morphogenesis and mechanosensing. On the basis of their protein
compositions and interactions with focal adhesions, stress fibers can
be divided into at least three categories. Dorsal stress fibers are non-
contractile actin bundles connected to focal adhesions at their distal
ends, whereas transverse arcs are contractile, myosin-II-containing
bundles that are not directly associated with focal adhesions. These
two structures serve as precursors for the third, ventral stress fibers,
which are thick, myosin-II-containing actin bundles linked to focal
adhesions at both their ends (Tojkander et al., 2012) (Fig. 3).
Studies on cultured human osteosarcoma cells revealed that they
express at least five Tpm isoforms that are functionally non-
redundant; depletion of any one of these isoforms led to drastic
defects in stress fiber assembly and/or myosin II recruitment
(Tojkander et al., 2011). The Tpm isoforms also display partially
distinct localization patterns within the stress fiber network,
suggesting that they specify the different actin filament
populations that are needed for stress fiber assembly (Fig. 3).
Although all isoforms are present in ventral stress fibers and
transverse arcs, where they display a periodic pattern and colocalize
with myosin II, their distribution in stress fiber precursors differs.
Tpm1.7 and Tpm4.2 are absent from dorsal stress fibers. Tpm1.6
decorates the entire length of dorsal stress fibers, whereas, Tpm2.1,
Tpm3.1 and Tpm3.2 localize only to the dorsal stress fiber segment
that overlaps with focal adhesions (Tojkander et al., 2011). It is also
interesting to note, that several formin proteins, including Dia1,
Dia2, Daam1 and FHOD1, are linked to stress fiber assembly
(Hotulainen and Lappalainen, 2006; Ang et al., 2010; Tojkander
et al., 2011; Schulze et al., 2014). Thus, it is possible that distinct
formin-Tpm pairs specify different actin filament populations
within the stress fiber network, similarly to what has recently been
demonstrated in fission yeast for other types of actin filament
structure (Johnson et al., 2014) (Fig. 1).
In addition to the stress fiber network, different Tpm isoforms
display specific functions in other actin-driven processes, such as in
bone remodeling by osteoclasts. The latter are giant multinucleate
cells, which contain actin-based adhesion structures that are
involved in bone-degradation processes. Osteoclasts express
several Tpm isoforms that have distinct subcellular localization
patterns. Tpm1.6 and Tpm3.1 display diffuse localization
throughout the interior of the cell, whereas Tpm4.2, Tpm1.8 and
Tpm1.9 localize to actin-rich adhesion structures, such as the
podosomes and the sealing zone (McMichael et al., 2006). RNA
interference studies further demonstrated that Tpm1.6 contributes to
osteoclast morphogenesis and motility, whereas Tpm4.2 is involved
in assembly and/or maintenance of adhesion structures (McMichael


















Fig. 3. Localization of Tpm isoforms within the stress fiber network.
Tpm1.7 and Tpm4.2 are absent from focal adhesion-anchored dorsal stress
fibers. Tpm2.1, Tpm3.1 and Tpm3.2 localize to focal adhesions, whereas
Tpm1.6 decorates the entire length of dorsal stress fibers. All main Tpm
isoforms are present in contractile transverse arcs and ventral stress fibers,
where they colocalize with myosin II. The figure was modified from Tojkander
et al. (2011).
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Specific Tpm isoforms are also involved in the dynamics of
intracellular organelles. For example, Tpm3.2 localizes to the Golgi
complex, whereas its close homolog Tpm3.1 is present in the stress
fiber network (Percival et al., 2004) and, upon insulin stimulation,
localizes to the cortical actin network (Kee et al., 2015).
Interestingly, specific formins – FMNL1 and INF2 – control the
integrity of the Golgi complex and might induce the assembly of
actin filament foci in the peri-Golgi region (Colón-Franco et al.,
2011; Ramabhadran et al., 2011). Moreover, a splice variant of
INF2 that contains a C-terminal prenyl group localizes to the
endoplasmic reticulum (ER) where it promotes the assembly of
myosin-II-containing actin filament structures that are involved in
ER-mediated mitochondrial fission (Korobova et al., 2013, 2014).
In the future, it will be interesting to examine the localization of
Tpm isoforms in Golgi- and ER-associated actin filament foci, in
order to reveal whether Tpm3.2 and/or some other Tpm isoforms
together with certain formins, indeed, specify the functions and
protein compositions of these structures.
Conclusions and perspectives
As discussed here, Tpms allow fungi and metazoans to assemble
compositionally distinct actin filaments by defining their preferred
interactions with actin-binding and myosin motors. From an
evolutionary viewpoint, in a complex milieu that contains many
actin-binding proteins and myosin motors there is a clear advantage
in building individual filaments that have the ability to discriminate
between all potential interactions to efficiently deliver the desired
functional outcome (Michelot and Drubin, 2011). In this regard,
homopolymers of specific Tpm isoforms would generate ‘fidelity
of function’ along the entire length of the actin filament that allows
it to act as ‘the unit of function’ as is the case in striated muscle
(Holmes and Lehman, 2008). Interactions of a given actin filament
with actin-binding proteins and myosin motors are expected to be
homogeneous along its entire length. This would also allow
multiple filaments with different functional capacities to
collaborate both in the same location and during the same process
by contributing to different functional roles. Examples for such
collaborations are, as discussed above, the assembly of stress fibers
(Tojkander et al., 2011) and the regulation of glucose uptake (Kee
et al., 2015).
One main question remains; why choose the option of multiple
Tpm isoforms rather than that of multiple actin proteins (Gunning
et al., 2015)? The answer could be that the existence of many
different Tpms provide both fine-tuning and fidelity of actin
filament function in the cytoskeleton. It is instructive to remember
that the contractile apparatus in metazoan striated muscles evolved
from the less-advanced fungal cytoskeletons. Thus, the key
principle of coordinated filament function, which is essential for
contractile tissue, was most probably already in place within the
cytoskeleton of these less-advanced species.
The ability of a cell to generate actin filaments with distinct
functional capabilities, simply by specifying the Tpm isoform
composition of the filament, has been used widely to regulate cell
and organ physiology. Genetic manipulation of mice has revealed
a remarkable lack of functional redundancy between Tpm
isoforms, which allowed us to identify the roles of different
types of actin filament in a variety of physiological processes. The
ability to link specific Tpm isoforms to distinct physiological
processes opens the door to therapeutic intervention. The recent
development of isoform-specific anti-Tpm drugs for the treatment
of cancer demonstrates the feasibility of targeting the actin
filament while avoiding the problems associated with targeting
actin (Stehn et al., 2013). It is expected that further knowledge
regarding Tpms will provide new mechanistic insights into the
functional specialization of the actin filament in addition to
therapeutic developments. The era of the generic actin filament has
finally passed.
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Galkin, V. E., Orlova, A., Schröder, G. F. and Egelman, E. H. (2010). Structural
polymorphism in F-actin. Nat. Struct. Mol. Biol. 17, 1318-1323.
Galkin, V. E., Orlova, A., Kudryashov, D. S., Solodukhin, A., Reisler, E.,
Schröder, G. F. and Egelman, E. H. (2011). Remodeling of actin filaments by
ADF/cofilin proteins. Proc. Natl. Acad. Sci. USA 108, 20568-20572.
Geeves, M. A. (2012). Thin filament regulation. In Comprehensive Biophysics, Vol.
4, (ed. E. H. Egelman), pp. 251-267. Elsevier.
Geeves, M. A., Hitchcock-DeGregori, S. E. and Gunning, P. W. (2015). A
systematic nomenclature for mammalian tropomyosin isoforms. J. Muscle Res.
Cell Motil. 2, 1-7.
Gimona, M., Kazzaz, J. A. and Helfman, D. M. (1996). Forced expression of
tropomyosin 2 or 3 in v-Ki-ras-transformed fibroblasts results in distinct phenotypic
effects. Proc. Natl. Acad. Sci. USA 93, 9618-9623.
Goins, L. M. andMullins, R. D. (2015). A novel tropomyosin isoform functions at the
mitotic spindle and Golgi in Drosophila. Mol. Biol. Cell. (in press).
Gunning, P., Hardeman, E., Jeffrey, P. and Weinberger, R. (1998). Creating
intracellular structural domains: spatial segregation of actin and tropomyosin
isoforms in neurons. Bioessays 20, 892-900.
Gunning, P. W., Ghoshdastider, U., Whitaker, S., Popp, D. and Robinson, R. C.
(2015). The evolution of compositionally and functionally distinct actin filaments.
J. Cell Sci. 128, 2009-2019.
Hendricks, M. andWeintraub, H. (1981). Tropomyosin is decreased in transformed
cells. Proc. Natl. Acad. Sci. USA 78, 5633-5637.
Hendricks, M. and Weintraub, H. (1984). Multiple tropomyosin polypeptides in
chicken embryo fibroblasts: differential repression of transcription by Rous
sarcoma virus transformation. Mol. Cell. Biol. 4, 1823-1833.
Hitchcock-DeGregori, S. E., Sampath, P. and Pollard, T. D. (1988). Tropomyosin
inhibits the rate of actin polymerization by stabilizing actin filaments. Biochemistry
27, 9182-9185.
Hodges, A. R., Krementsova, E. B., Bookwalter, C. S., Fagnant, P. M.,
Sladewski, T. E. and Trybus, K. M. (2012). Tropomyosin is essential for
processive movement of a class V myosin from budding yeast. Curr. Biol. 22,
1410-1416.
Holmes, K. C. and Lehman, W. (2008). Gestalt-binding of tropomyosin to actin
filaments. J. Muscle Res. Cell Motil. 29, 213-219.
Hook, J., Lemckert, F., Qin, H., Schevzov, G. and Gunning, P. (2004). Gamma
tropomyosin gene products are required for embryonic development. Mol. Cell.
Biol. 24, 2318-2323.
Hook, J., Lemckert, F., Schevzov, G., Fath, T. andGunning, P. (2011). Functional
identity of the gamma tropomyosin gene: implications for embryonic development,
reproduction and cell viability. Bioarchitecture 1, 49-59.
Hotulainen, P. and Lappalainen, P. (2006). Stress fibers are generated by two
distinct actin assembly mechanisms in motile cells. J. Cell Biol. 173, 383-394.
Ishikawa, R., Yamashiro, S. andMatsumura, F. (1989a). Differential modulation of
actin-severing activity of gelsolin by multiple isoforms of cultured rat cell
tropomyosin. Potentiation of protective ability of tropomyosins by 83-kDa
nonmuscle caldesmon. J. Biol. Chem. 264, 7490-7497.
Ishikawa, R., Yamashiro, S. and Matsumura, F. (1989b). Annealing of gelsolin-
severed actin fragments by tropomyosin in the presence of Ca2+. Potentiation of
the annealing process by caldesmon. J. Biol. Chem. 264, 16764-16770.
Jagatheesan, G., Rajan, S. and Wieczorek, D. F. (2010a). Investigations into
tropomyosin function using mouse models. J. Mol. Cell. Cardiol. 48, 893-898.
Jagatheesan, G., Rajan, S., Ahmed, R. P. H., Petrashevskaya, N., Boivin, G.,
Arteaga, G. M., Tae, H.-J., Liggett, S. B., Solaro, R. J. and Wieczorek, D. F.
(2010b). Striated muscle tropomyosin isoforms differentially regulate cardiac
performance and myofilament calcium sensitivity. J. Muscle Res. Cell Motil. 31,
227-239.
Jalilian, I., Heu, C., Cheng, H., Freittag, H., Desouza, M., Stehn, J. R., Bryce,
N. S., Whan, R. M., Hardeman, E. C., Fath, T. et al. (2015). Cell elasticity is
regulated by the tropomyosin isoform composition of the actin cytoskeleton. PLOS
ONE 10, e0126214.
Johnson, M., East, D. A. and Mulvihill, D. P. (2014). Formins determine the
functional properties of actin filaments in yeast. Curr. Biol. 24, 1525-1530.
Kee, A. J., Gunning, P. W. and Hardeman, E. C. (2009a). A cytoskeletal
tropomyosin can compromise the structural integrity of skeletal muscle. Cell Motil.
Cytoskeleton 66, 710-720.
Kee, A. J., Gunning, P. W. and Hardeman, E. C. (2009b). Diverse roles of the actin
cytoskeleton in striated muscle. J. Muscle Res. Cell Motil. 30, 187-197.
Kee, A. J., Yang, L., Lucas, C. A., Greenberg, M. J., Martel, N., Leong, G. M.,
Hughes, W. E., Cooney, G. J., James, D. E., Ostap, E. M. et al. (2015). An actin
filament population defined by the tropomyosin Tpm3.1 regulates glucose uptake.
Traffic 16, 691-711.
Kis-Bicskei, N., Vig, A., Nyitrai, M., Bugyi, B. and Talián, G. C. (2013). Purification
of tropomyosin Br-3 and 5NM1 and characterization of their interactions with actin.
Cytoskeleton 70, 755-765.
Klip, A., Sun, Y., Chiu, T. T. and Foley, K. P. (2014). Signal transduction meets
vesicle traffic: the software and hardware of GLUT4 translocation. Am. J. Physiol.
Cell Physiol. 306, C879-C886.
Kojima, H., Ishijima, A. and Yanagida, T. (1994). Direct measurement of stiffness
of single actin filaments with and without tropomyosin by in vitro
nanomanipulation. Proc. Natl. Acad. Sci. USA 91, 12962-12966.
Korobova, F., Ramabhadran, V. and Higgs, H. N. (2013). An actin-dependent step
in mitochondrial fission mediated by the ER-associated formin INF2.Science 339,
464-467.
Korobova, F., Gauvin, T. J. and Higgs, H. N. (2014). A role for myosin II in
mammalian mitochondrial fission. Curr. Biol. 24, 409-414.
Kotadiya, P., McMichael, B. K. and Lee, B. S. (2008). High molecular weight
tropomyosins regulate osteoclast cytoskeletal morphology. Bone 43, 951-960.
Kuhn, T. B. and Bamburg, J. R. (2008). Tropomyosin and ADF/cofilin as
collaborators and competitors. Adv. Exp. Med. Biol. 644, 232-249.
Lazarides, E. (1975). Tropomyosin antibody: the specific localization of
tropomyosin in nonmuscle cells. J. Cell Biol. 65, 549-561.
Lazarides, E. (1976). Two general classes of cytoplasmic actin filaments in tissue
culture cells: the role of tropomyosin. J. Supramol. Struct. 5, 531-563.
Lees, J. G., Ching, Y. W., Adams, D. H., Bach, C. T. T., Samuel, M. S., Kee, A. J.,
Hardeman, E. C., Gunning, P., Cowin, A. J. and O’Neill, G. M. (2013).
Tropomyosin regulates cell migration during skin wound healing. J. Invest.
Dermatol. 133, 1330-1339.
Lehman, W. and Craig, R. (2008). Tropomyosin and the steric mechanism of
muscle regulation. Adv. Exp. Med. Biol. 644, 95-109.
Lehrer, S. S. and Geeves, M. A. (2014). The myosin-activated thin filament
regulatory state, M–-open: a link to hypertrophic cardiomyopathy (HCM). J. Muscle
Res. Cell Motil. 35, 153-160.
Leonardi, C. L., Warren, R. H. and Rubin, R. W. (1982). Lack of tropomyosin
correlates with the absence of stress fibers in transformed rat kidney cells.
Biochim. Biophys. Acta 720, 154-162.
Li,W. andGao, F. B. (2003). Actin filament-stabilizing protein tropomyosin regulates
the size of dendritic fields. J. Neurosci. 23, 6171-6175.
Lim, C.-Y., Bi, X., Wu, D., Kim, J. B., Gunning, P. W., Hong, W. and Han, W.
(2015). Tropomodulin3 is a novel Akt2 effector regulating insulin-stimulated
GLUT4 exocytosis through cortical actin remodeling. Nat. Commun. 6, 5951.
Lin, C. S. and Leavitt, J. (1988). Cloning and characterization of a cDNA encoding
transformation-sensitive tropomyosin isoform 3 from tumorigenic human
fibroblasts. Mol. Cell. Biol. 8, 160-168.
Liu, H. and Bretscher, A. (1989). Disruption of the single tropomyosin gene in yeast
results in the disappearance of actin cables from the cytoskeleton. Cell 57,
233-242.
Liu, H. and Bretscher, A. (1992). Characterization of TPM1 disrupted yeast cells
indicates an involvement of tropomyosin in directed vesicular transport. J. Cell
Biol. 118, 285-299.
Marguerat, S., Schmidt, A., Codlin, S., Chen, W., Aebersold, R. and Bähler, J.
(2012). Quantitative analysis of fission yeast transcriptomes and proteomes in
proliferating and quiescent cells. Cell 151, 671-683.
Martin, S. G. and Chang, F. (2006). Dynamics of the formin for3p in actin cable
assembly. Curr. Biol. 16, 1161-1170.
Martin, C., Schevzov, G. and Gunning, P. (2010). Alternatively spliced N-terminal
exons in tropomyosin isoforms do not act as autonomous targeting signals.
J. Struct. Biol. 170, 286-293.
Marttila, M., Lehtokari, V.-L., Marston, S., Nyman, T. A., Barnerias, C., Beggs,
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